- 406
- Episodes
- 68
- Transcribed
- 71
- Ratings
- Weekly
- Cadence
- 2020
- First episode
- 38K
- YouTube views
About BioCentury This Week
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs. For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
- Publisher
- BioCentury
- Category
- business · science · science
- Language
- en
- Explicit
- No
- First episode
- 22 Apr 2020
- Latest episode
- 7 Nov 2026
Latest episodes
68 of 406 episodes have a transcript.
7 Nov 2026TRANSCRIPT
Ep. 396 - China’s first-order innovation
3 Nov 2026TRANSCRIPT
Ep. 395 - ESMO analysis & Auchincloss proposal
27 Oct 2026TRANSCRIPT
Ep. 394 - Security concerns in U.S., China reshaping biotech
Inside a recent episode
Ep. 396 - China’s first-order innovation
Published 7 Nov 2026 · Transcript excerpt
[…] You know, you can also be first in class by taking a new modality against a validated target, which China has been doing for a while. But we're really starting to see, as I said, it's a very, it's a signal. […]
Read the full transcript with a Pod Engine plan.
See plansWho has been a guest on BioCentury This Week
Names identified in recent episode analyses. Showing up to five guests.
- Weihao Xu
- Matthew Hewitt
- Jack O’Meara
- BioCentury’s analysts
- Oskar Slotboom
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
- YouTube views
- 37,894
- Score snapshot 15 Sept 2025
- Apple Podcasts (US)
- 4.7 / 5
- 35 ratings
- Spotify
- 4.8 / 5
- 36 ratings
Podcast Authority Score: 76 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
- Quality
- 78
- Social presence
- 0
- YouTube
- 85
- Engagement
- 98
Host of BioCentury This Week?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show
Podcast research with Pod Engine